IBC Presents Nucleic Acids Technologies for Diagnostics

IBC's 3rd Annual Nucleic Acids Technologies for Diagnostics is scheduled to take place on May 20-21, 2008 at the Red Rock Casino, Resort & Spa in Las Vegas, Nevada. This event is a forum for suppliers and end-users to forge collaborations and discuss the technological, regulatory, operational and business considerations surrounding the manufacturing of IVDs. It is designed to provide information on developments in regulatory pathways, business landscape and emerging technologies. Delegates will have the opportunity to meet with those involved in development, application and validation of methods for synthesis, modification, purification and characterization of any type of oligonucleotide for IVD and therapeutic applications. Presentations on recent U.S. and international regulatory developments from FDA and industrial specialists will highlight management insights and important business trends in the IVD market. The blend of presentations at Nucleic Acids Technologies for Diagnostics deals with new technologies and scientific developments together with business and regulatory considerations.

Keynote Presentations:

--  Steven I. Gutman, M.D.
    Director, Office of In Vitro Diagnostic Device Evaluation and Safety,
    CDRH, U.S. Food and Drug Administration
--  Petra Kaars-Wiele, Ph.D.
    Senior Director, International Regulatory Affairs and Affiliate
    Compliance, Diagnostic Division, Abbott Laboratories, Germany
--  Ichiro Hirao, Ph.D.
    Team Leader, Nucleic Acid Synthetic Biology Research Team, RIKEN
    Genomic Sciences Center (GSC); President, TagCyx Biotechnologies, Japan
    

This meeting is held concurrently with IBC's TIDES 2008: Oligonucleotide and Peptide® Technology and Product Development Conference, designed to provide industry updates on developments on regulatory pathways, business landscape, analytical methods and validation, and emerging technologies. It covers manufacturing, formulation, delivery, process and analytical development and overall market trends for peptide- and oligonucleotide-based therapeutics and diagnostics.

For up-to-date information and to register for this event, visit www.IBCLifeSciences.com/diagnostics .

To apply for a press pass, please contact kpatterson@ibcusa.com .

About IBC Life Sciences

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value. For more information, visit: http://www.IBCLifeSciences.com .

Contact: Kerry Patterson IBC Life Sciences (508) 614-1423 Email Contact